Publications by authors named "Sumanta K Pal"

100Publications

Immune Related Adverse Events: Classification and Management Approaches in Advanced Kidney Cancer.

Cancer J 2020 Sep/Oct;26(5):432-440

From the Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000473DOI Listing
September 2020

Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors.

Eur Urol 2020 Oct 19;78(4):498-502. Epub 2020 Aug 19.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2020.07.011DOI Listing
October 2020

Switch maintenance therapy for advanced bladder cancer: A paradigm shift in 2020.

Cancer Treat Res Commun 2020 31;24:100202. Epub 2020 Jul 31.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100202DOI Listing
July 2020

Immunotherapy-based combination strategies for advanced urothelial cancer: A long quest.

Cancer 2020 Aug 5. Epub 2020 Aug 5.

Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.33068DOI Listing
August 2020

Sequencing Therapies for Metastatic Renal Cell Carcinoma.

Urol Clin North Am 2020 Aug 11;47(3):305-318. Epub 2020 Jun 11.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2020.04.008DOI Listing
August 2020

The landscape of contemporary clinical trials for untreated metastatic clear cell renal cell carcinoma.

Cancer Treat Res Commun 2020 12;24:100183. Epub 2020 Jun 12.

City of Hope Comprehensive Cancer Center, Los Angeles, CA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100183DOI Listing
June 2020

Genomic profiling in renal cell carcinoma.

Nat Rev Nephrol 2020 Aug 19;16(8):435-451. Epub 2020 Jun 19.

Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41581-020-0301-xDOI Listing
August 2020

Tivozanib in renal cell carcinoma: a new approach to previously treated disease.

Ther Adv Med Oncol 2020 22;12:1758835920923818. Epub 2020 May 22.

Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835920923818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249546PMC
May 2020

A drug delivery perspective on intratumoral-immunotherapy in renal cell carcinoma.

Urol Oncol 2020 May 10. Epub 2020 May 10.

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2020.03.018DOI Listing
May 2020

Evolving treatment paradigm in metastatic non clear cell renal cell carcinoma.

Cancer Treat Res Commun 2020 Mar 17;23:100172. Epub 2020 Mar 17.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100172DOI Listing
March 2020

Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers.

Nat Rev Urol 2020 May 17;17(5):271-291. Epub 2020 Mar 17.

Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-020-0297-9DOI Listing
May 2020

Potential Roles for PD-1 Inhibition and Cabozantinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma.

Oncologist 2020 03 15;25(3):186-188. Epub 2019 Oct 15.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0657DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066721PMC
March 2020

Capturing recurrence in urothelial carcinoma: "more than meets the eye".

Transl Androl Urol 2019 Dec;8(Suppl 5):S524-S527

Department of Medicine, Division of Oncology, University of Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tau.2019.12.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989855PMC
December 2019

Squamous Transformation of Prostate Adenocarcinoma: A Report of Two Cases With Genomic Profiling.

Clin Genitourin Cancer 2020 06 4;18(3):e289-e292. Epub 2019 Dec 4.

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.11.020DOI Listing
June 2020

Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors.

Ther Adv Med Oncol 2019 25;11:1758835919890285. Epub 2019 Nov 25.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Maroncelli 40, Meldola, 47014, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835919890285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878604PMC
November 2019

Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence.

Mol Cancer Ther 2019 12;18(12):2185-2193

City of Hope National Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-1399DOI Listing
December 2019

Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway Inhibition.

Cancer Discov 2019 12;9(12):1646-1649

Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-19-1156DOI Listing
December 2019

Potential Roles for PD-1 Inhibition and Cabozantinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma.

Oncologist 2019 Oct 15. Epub 2019 Oct 15.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0657DOI Listing
October 2019

First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options.

Target Oncol 2019 12;14(6):639-645

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-019-00676-yDOI Listing
December 2019

First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.

Eur Urol Oncol 2019 Nov 4;2(6):708-715. Epub 2019 Oct 4.

Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.09.002DOI Listing
November 2019

Factors that influence the androgen receptor cistrome in benign and malignant prostate cells.

Mol Oncol 2019 12 13;13(12):2616-2632. Epub 2019 Oct 13.

Deparment of Medical Oncology, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/1878-0261.12572DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887583PMC
December 2019

Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?

BJU Int 2019 09;124(3):361-362

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14877DOI Listing
September 2019

Patterns of treatment in metastatic renal cell carcinoma for older versus younger patients.

J Geriatr Oncol 2020 May 8;11(4):724-726. Epub 2019 Aug 8.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.07.002DOI Listing
May 2020

Different roles of peroxisome proliferator-activated receptor gamma isoforms in prostate cancer.

Am J Clin Exp Urol 2019 15;7(3):98-109. Epub 2019 Jun 15.

Department of Medical Oncology, City of Hope 1500 East Duarte Road, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627550PMC
June 2019

Characterizing the Wnt Pathway in Advanced Prostate Cancer: When, Why, and How.

Eur Urol 2020 01 9;77(1):22-23. Epub 2019 Jul 9.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.06.029DOI Listing
January 2020

Ideal Glucocorticoid Regimen With Abiraterone Acetate: Options and Challenges.

JAMA Oncol 2019 Jun 27. Epub 2019 Jun 27.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.1008DOI Listing
June 2019

Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?

Eur Urol Oncol 2019 07 18;2(4):365-378. Epub 2019 May 18.

Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.04.007DOI Listing
July 2019

The Changing Landscape of Management of Metastatic Renal Cell Carcinoma: Current Treatment Options and Future Directions.

Curr Treat Options Oncol 2019 04 1;20(5):41. Epub 2019 Apr 1.

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-019-0638-1DOI Listing
April 2019

Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium.

ACS Omega 2019 Feb 1;4(2):2472-2481. Epub 2019 Feb 1.

Department of Medical Oncology and Department of Molecular Medicine, City of Hope, East Duarte Road, 1500 Duarte, California, United States.

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/10.1021/acsomega.8b03205
Publisher Site
http://dx.doi.org/10.1021/acsomega.8b03205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410682PMC
February 2019

The Microbiome and Genitourinary Cancer: A Collaborative Review.

Eur Urol 2019 04 15;75(4):637-646. Epub 2019 Jan 15.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183105
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.12.043DOI Listing
April 2019

Mutations in renal cell carcinoma.

Urol Oncol 2020 Oct 23;38(10):763-773. Epub 2018 Nov 23.

Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439183043
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2018.10.027DOI Listing
October 2020

Biomarkers in renal-cell carcinoma: building on clinical paradigms.

Lancet Oncol 2018 12 8;19(12):1560-1561. Epub 2018 Nov 8.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30674-0DOI Listing
December 2018

Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice.

Kidney Cancer 2017 Nov 27;1(2):99-105. Epub 2017 Nov 27.

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://www.medra.org/servlet/aliasResolver?alias=iospress&am
Publisher Site
http://dx.doi.org/10.3233/KCA-170019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179117PMC
November 2017

Assessment of distress and quality of life in rare cancers.

Psychooncology 2018 12 25;27(12):2740-2746. Epub 2018 Sep 25.

Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.4873DOI Listing
December 2018

Advances in the Treatment of Metastatic Renal Cell Carcinoma.

Cancer Treat Res 2018;175:127-137

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-3-319-93339-9_6
Publisher Site
http://dx.doi.org/10.1007/978-3-319-93339-9_6DOI Listing
June 2019

Adjuvant treatment in renal cell carcinoma.

Clin Adv Hematol Oncol 2018 Aug;16(8):555-563

City of Hope Comprehensive Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
August 2018

Targeting Endoglin to Treat Metastatic Renal Cell Carcinoma: Lessons from Osler-Weber-Rendu Syndrome.

Oncologist 2019 02 23;24(2):143-145. Epub 2018 Aug 23.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369955PMC
February 2019

Cytoreductive nephrectomy: questions remain after CARMENA.

Nat Rev Urol 2018 09;15(9):530-532

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-018-0064-3DOI Listing
September 2018

Regarding the Congruence Between 2 Circulating Tumor DNA Sequencing Assays.

JAMA Oncol 2018 10;4(10):1429-1430

City of Hope Comprehensive Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.2317DOI Listing
October 2018

Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Eur J Surg Oncol 2018 09 5;44(9):1439-1445. Epub 2018 Jun 5.

Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2018.05.026DOI Listing
September 2018

Next Generation Sequencing in metastatic castrate-resistant prostate cancer.

Urol Case Rep 2018 Jul 14;19:60-62. Epub 2018 May 14.

Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eucr.2018.05.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991312PMC
July 2018

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma.

Case Rep Oncol 2018 May-Aug;11(2):276-280. Epub 2018 May 17.

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000489995DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981597PMC
May 2018

Treatment of metastatic renal cell carcinoma in older patients: A network meta-analysis.

J Geriatr Oncol 2019 01 1;10(1):149-154. Epub 2018 Jun 1.

Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States. Electronic address:

View Article

Download full-text PDF

Source
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2
Web Search
https://linkinghub.elsevier.com/retrieve/pii/S18794068183008
Publisher Site
http://dx.doi.org/10.1016/j.jgo.2018.05.010DOI Listing
January 2019

Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer.

Eur Urol 2018 08 3;74(2):239-240. Epub 2018 May 3.

Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland; Department of Oncology and Haematology, University Hospital Berne, Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.04.024DOI Listing
August 2018

Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma.

Eur Urol 2018 07;74(1):124-128

Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183025
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.03.032DOI Listing
July 2018

Second-Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review.

Oncologist 2018 05 27;23(5):540-555. Epub 2018 Feb 27.

Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0534DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947457PMC
May 2018

The androgen receptor malignancy shift in prostate cancer.

Prostate 2018 05 23;78(7):521-531. Epub 2018 Feb 23.

Department of Medical Oncology, City of Hope National Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23497DOI Listing
May 2018